Mwb: Bayer Achieving Midterm Targets for Crop Science Division 'Increasingly Credible'

09:12 AM EDT, 09/03/2026 (MT Newswires) -- Mwb Research is optimistic about Bayer's (BAYN.F) ability to deliver its medium-term targets for the crop science segment, saying the achievement looks "increasingly credible" amid visible progress thus far in executing its Five-Year Framework strategy. "Bayer's Crop Science update strengthens confidence in the recovery, with execution on costs, portfolio simplification and working capital providing a more tangible path to higher margins and cash generation. Growth should also become broader over time as Corn expands, Soy benefits from new launches and licensing remains a relatively stable earnings contributor. The pipeline adds further upside, although much of the larger commercial opportunity sits beyond 2029," analysts said Thursday. "Together with the improving legal and balance-sheet outlook and a gradually improving Pharma growth profile, this supports our positive investment case." The research firm also sees the dedicated Ruveon structure as a positive factor, expecting this to help contain pricing volatility in the German company's US glyphosate business over time and allow management to sharpen its focus on the core portfolio. The stock's buy rating and price target of 65 euros were reaffirmed.